直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

American Regent, Inc. v. Pharmacosmos Therapeutics Inc. et al.

American Regent, Inc.

Pharmacosmos Therapeutics Inc. et al., Pharmacosmos Therapeutics Inc.

Successfully represented American Regent in litigation in the District of New Jersey against Pharmacosmos and their branded drug, Monoferric®, related to American Regent patents covering the use of iron carbohydrate complexes for the treatment of iron deficiency diseases. The case resulted in a favorable settlement for our client. This representation follows successful representation of American Regent in related post-grant review proceeding.

Pharmacosmos Therapeutics Inc. et al., Pharmacosmos Therapeutics Inc. v. American Regent, Inc., PGR2020-00009, PTAB, Judges Tornquist, Franklin, Wisz

American Regent, Inc. v. Pharmacosmos Therapeutics Inc. et al., Pharmacosmos Therapeutics Inc., 3:20-cv-01350, D.N.J., Judges Goodman, Martinotti, Quraishi

Related Professionals

Cora R. Holt
Partner
Washington, DC
+1 202 408 4334
Email
M. David Weingarten, Ph.D.
Partner
Atlanta, GA
+1 404 653 6457
Email
Emily R. Gabranski
Partner
Washington, DC
+1 202 408 4331
Email
Kathryn R. Judson
Associate
Atlanta, GA
+1 404 653 6466
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Branded Hatch-Waxman (ANDA) Litigation and Trials

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.

Sarepta Therapeutics, Inc. et al.

Vifor (International) AG and American Regent, Inc. v. Mylan Labs. Ltd. et al.

Vifor (International) AG and American Regent, Inc.

Rocket Pharmaceuticals, Inc. v. Lexeo Therapeutics, Inc., et al.

Rocket Pharmaceuticals, Inc.

Lo v. Quake

Sequenom, Inc. et al

Genzyme Corporation v. Sarepta Therapeutics, Inc. et al.

Sarepta Therapeutics, Inc. et al.

Volkswagen Group of America, Inc. et al. v. Arigna Technology Limited

Volkswagen Group of America, Inc. et al.

Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.

Biogen MA Inc. et al.

Aerin Medical Inc. et al. v. Neurent Medical Inc. et al.

Aerin Medical Inc. et al.

Uniloc USA, Inc. et al v. Tencent America, LLC

Tencent America LLC

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP